CONSULTING AGREEMENT (As Amended and Restated)Consulting Agreement • May 9th, 2022 • Enanta Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledMay 9th, 2022 Company Industry JurisdictionThis Consulting Agreement (this “Agreement”) is entered into effective as of the 23rd day of February, 2022 (the “Signature Date”) between Enanta Pharmaceuticals, Inc. (the “Company”), a Delaware corporation, with offices at 500 Arsenal Street, Watertown, MA 02472, and Nathalie Adda, M.D, having a principal residence in Cambridge, Massachusetts (“Consultant”) (each, a “Party” and collectively, the “Parties”) in order to amend and restate in its entirety the Consulting Agreement (the “Original Agreement” entered into effective as of July 14, 2021 between the Parties.
CONSULTING AGREEMENTConsulting Agreement • November 24th, 2021 • Enanta Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledNovember 24th, 2021 Company Industry JurisdictionThis Consulting Agreement (this “Agreement”) is entered into effective as of the 14th day of July, 2021 (the “Signature Date”) between Enanta Pharmaceuticals, Inc. (the “Company”), a Delaware corporation, with offices at 500 Arsenal Street, Watertown, MA 02472, and Nathalie Adda, M.D, having a principal residence in Cambridge, Massachusetts (“Consultant”) (each, a “Party” and collectively, the “Parties”).